glp-1 and serotonin Interaction of serotonin/GLP-1 circuitry in a dual preclinical model for psychiatric disorders metabolic dysfunction New research shows GLP-1 medications

Gentle walking is acceptable after 24 hours, but avoid strenuous activity for at least 48 hours

Key takeaways Cleveland Clinic real-world data presented at ASCO 2026 found patients who started a GLP-1 receptor agonist (semaglutide or tirzepatide) after a breast cancer diagnosis were about 43% less likely to progress to Stage IV disease than patients who started a DPP-4 inhibitor (hazard ratio 0.57, 95% CI 0.46 to 0.71

The idea behind the campaign is, peak health doesn't require peak effort, says Scherr

In CarnoSyn beta-alanine, one of its primary mechanisms of action is its ability to enhance intracellular buffering capacity, which results in a greater tolerance for sustained anaerobic activity